Alzheimer's Disease

Estrogen Therapy Does Not Appear To Slow Progression

Published in Women's Health Weekly, March 11th, 2000

Estrogen replacement therapy does not appear to alter the mental deterioration associated with Alzheimer disease (AD), according to an article in the February 23, 2000, issue of The Journal of the American Medical Association.

Ruth A. Mulnard, RN, DNSc, from the University of California, Irvine, and colleagues enrolled women at sites that participated in the Alzheimer's Disease Cooperative Study (ADCS) to assess whether estrogen replacement therapy is associated with improving or stabilizing the deterioration of mental functioning related to AD.

The women enrolled in the study were diagnosed with mild to moderate AD. They were randomly...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2000-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry